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The BfR publishes workshop report based on the expert meeting on endocrine 
disruptors 
BfR communication No. 11/2016, 4 May 2016 
On the occasion of an expert meeting organised by the Federal Institute for Risk 
Assessment (BfR) held in Berlin on 11 and 12 April 2016, a consensus was reached on 
the identification of endocrine disruptors. The BfR has now published the workshop 
report from the conference. It contains, among other things, the consensus paper 
agreed by all participants. The report is published at 
http://www.bfr.bund.de/cm/349/scientific-principles-for-the-identification-of-endocrine-
disrupting-chemicals.pdf  
The presentations given at the meeting as well as a preliminary conclusion from the 
conference are available as videos on the website of the BfR: 
http://www.bfr.bund.de/en/international_expert_meeting_on_endocrine_disruptors-
197246.html   
The consensus paper was published in the scientific journal Archives of 
Toxicology http://link.springer.com/article/10.1007/s00204-016-1866-9.
Twenty-three internationally renowned scientists took part in the meeting. In addition, 
four observers from the European Commission, the European Food Safety Authority 
(EFSA) and the European Chemicals Agency (ECHA) were present. Among other 
things, the consensus paper lists the criteria for identifying endocrine disrupting 
substances. The scientific principles are an important precondition for creating 
uniform criteria at EU level as a basis for future human health assessments of 
substances and products with endocrine disrupting properties. The results of the 
meeting may therefore support the European Commission in developing regulatory 
criteria for the identification of endocrine disruptors in pesticides and other chemicals 
and products. 
The expert meeting was designed as a discussion platform for scientists. Hosting the 
event, the BfR sought to facilitate the exchange of ideas between scientists viewing 
the issue from different standpoints. As a scientific institution for risk assessment in 
Germany, the BfR began developing and publicising its own scientific position on the 
identification and characterisation of endocrine disrupting substances a few years 
ago: http://link.springer.com/article/10.1007/s00003-016-1016-6.  
The current discussion focuses on substances or substance mixtures which alter the function 
of the endocrine system and consequently causes adverse health effects in an ntact 
organism, or its progeny, or in (sub)populations. Such substances referred to as “endocrine 
disruptors” include, for example, industrial chemicals or active ingredients in biocides or 
pesticides. Some endocrine active substances naturally occur in plants, however, for 
example as ingredients (phytoestrogens). Since such substances in principle play a role in all 
regulatory areas, it was emphasised that in all regulatory domains procedures and 
assessment should adopt the “one substance - one assessment” principle. 
An inalienable condition for legal regulation is, however, that substances with endocrine 
disrupting effects that adversely affect the health of an organism or its progeny can be 
identified with certainty within the regulatory framework. Unfortunately, endocrine disruptors 
are not a clearly defined group of substances which may be identified as such on the basis of 
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their structural characteristics. Scientific criteria for identifying endocrine-disrupting 
substances have been the subject of controversial discussion among experts for several 
years. 
At the end of 2014, the European Commission instructed DG Health and Food Safety, to 
define conclusive criteria for the regulation of endocrine disruptors, so that they could in 
future be used in European pesticide and biocide legislation. Due to the globally increasing 
concern with regard to possible adverse effects of endocrine disruptors, active substances 
used in biocide and pesticide products subject to approval within the EU are in future to be 
tested more rigorously for endocrine disrupting properties. 
The expert meeting held in Berlin on 11 and 12 April 2016 was attended by 23 scientists from 
Europe, the USA and Japan. They discussed the foundations as well as open questions 
relating to the identification of endocrine disruptors. The two-day expert conference notably 
focused on the following questions: 
 How should endocrine disruptors be defined in the regulatory context of health 
assessment? 
 What are the general principles of endocrine effects from a toxicological, 
pharmacological and endocrinological viewpoint? 
 Which sources of uncertainty influence the identification of endocrine disrupting 
substances in terms of regulatory decision-making? 
 Which adverse effects caused by endocrine disruptors can already be determined 
using existing testing methods? 
 Which scientific research activities should be initiated to ensure better identification of 
endocrine disruptors? 
The goal of the scientific discourse was to discuss questions and, where possible, find 
solutions to current scientific divergences. Hosting the event, the BfR facilitated the 
discussion.  
Independently from this expert conference, the BfR began developing and publicising its own 
scientific position on the identification and characterisation of endocrine disrupting 
substances a few years ago. This concept suggested by the BfR provides for the 
characterisation of endocrine disruptors by means of a decision matrix based on the 
principles of toxicological assessment. This characterisation should include: 
 the severity of adverse health effects 
 the question whether the observed adverse effects are reversible 
 the potency of the substance 
 and other aspects such as consistency. 
 
These decision criteria should help to categorise substances into one of three groups: ((1) 
“Endocrine disruptor”, (2) “Suspected endocrine disruptor” or (3) “Endocrine-active 
substances”). This categorisation is in line with the recommendation of the EU Commission 
roadmap (European Commission 2014). On the basis of these categories, regulatory 
decisions could be made, for example in the form of an exclusion from authorisation of 
endocrine disruptors in plant protection products and biocidal products. 
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Further information is available on the BfR website under “endocrine disruptors”: 
http://www.bfr.bund.de/de/a-z_index/endokrine_disruptoren-32448.html#fragment-2 
 
European Commission 2014: Defining criteria for identifying Endocrine Disruptors in the 
context of the implementation of the Plant Protection Product Regulation and Biocidal 
Products Regulation 
http://ec.europa.eu/smart-
regulation/impact/planned_ia/docs/2014_env_009_endocrine_disruptors_en.pdf 
 
